Fingerprint
Dive into the research topics where Ans T. van der Ploeg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A comprehensive study on the effect of alglucosidase alpha and immunomodulation on survival, motor and cardiac outcome, creatine kinase and antibody titers in classic infantile Pompe disease: the Monza experience
Faraguna, M. C., Crescitelli, V., Bonanomi, S., Kullmann, G. A., Boffi, M. L., Pretese, R., Risca, G., Tedesco, L. M., Pozzi, K., Serafini, M., van den Hout, J. M. P., van der Ploeg, A. T., Balduzzi, A. C. & Gasperini, S., Apr 2026, In: Current Opinion in Immunology. 99, p. 102725 14 p., 102725.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile4 Downloads (Pure) -
Quantification of muscle glycogen distribution in Pompe disease using 7 Tesla 13C NMR spectroscopy
Beha, G. H., Stemmerik, M. G., Boer, V. O., Van der Ploeg, A. T., Van der Beek, N. A., Andersen, H., Marsman, A., Jacobsen, L. N., Theunissen, M. T. M., Petersen, E. T. & Vissing, J., 1 Mar 2026, In: Journal of Neurology, Neurosurgery and Psychiatry. 97, 3, p. 201-203 3 p., jnnp-2025-336628.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Citations (Scopus)4 Downloads (Pure) -
Safety profile of idursulfase administered at home in patients with mucopolysaccharidosis II enrolled in the Hunter Outcome Survey
Burton, B. K., Guffon, N., Roberts, J., Van der Ploeg, A. T., Jones, S. A., Audi, J., Botha, J., Whiteman, D. A. H., Giugliani, R. & Muenzer, J., Mar 2026, In: Molecular Genetics and Metabolism. 147, 3, 10 p., 109734.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile4 Downloads (Pure) -
Miglustat: a first-in-class enzyme stabilizer for cipaglucosidase alfa for the treatment of late-onset Pompe disease
Hopkin, R. J., Byrne, B. J., Dimachkie, M. M., Kishnani, P. S., Mozaffar, T., Roberts, M., Schoser, B., van der Beek, N. A. M. E., van der Ploeg, A. T., Wenninger, S., Brudvig, J., Fox, B., Holdbrook, F., Jain, V., Johnson, F., Zhang, J. & Parenti, G., 26 Feb 2026, In: Therapeutic Advances in Rare Disease. 7Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile2 Downloads (Pure) -
Can Alpha-Glucosidase Activity in Plasma or Leukocytes Serve as a Biomarker for Future Gene Therapy in Classic Infantile Pompe Disease?
Faraguna, M. C., Lambregts, D. A. M., Barzel, I., Jacobs, E. H., Hoogeveen-Westerveld, M., van der Beek, N. A. M. E., Pijnappel, W. W. M. P., Gasperini, S., Preijers, T., van den Hout, J. M. P. & van der Ploeg, A. T., Jan 2026, In: BioDrugs. 40, 1, p. 163-173 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Downloads (Pure)